Ethnic differences in risks of adverse reactions: is personalised drug treatment better with pharmacokinetic modelling?
Millson
David S
DS
D002317:Cardiovascular Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D020834:Ethnopharmacology; D006801:Humans; D044469:Racial Groups / Q000208:ethnology*; D012307:Risk Factors
D002317:Cardiovascular Agents